Monthly Archives April 26, 2016

By Brett Drummond When we talk about basic science discoveries related to multiple sclerosis, we often finish the article by explaining that this finding is likely to be 5-10 years away from potentially...

AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR REBECCA SPAIN – OREGON HEALTH AND SCIENCES UNIVERSITY (OHSU), VA PORTLAND HEALTH CARE SYSTEM BD: Brett Drummond,...

AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR TOMAS KALINCIK – MELBOURNE BRAIN CENTRE, ROYAL MELBOURNE HOSPITAL BD: Brett Drummond, MStranslate TK: Dr Tomas Kalincik,...

A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially reverse damage to the optic nerve in people with multiple...

Research Summary: Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis The background Current MS therapies mostly work to suppress...

Research Summary: Regulation of prefrontal cortex myelination by the microbiota The Background In recent times, there has been an increasing focus placed on the role that the gut microbiome (composed of...

Research Summary: Rituximab versus fingolimod after natalizumab in multiple sclerosis patients The background Whilst natalizumab has emerged as a potent treatment for multiple sclerosis (MS), it is also...

An MStranslate Opinion Piece When I was younger, I was cast in the role of Robin Hood in a school musical.  I robbed from the rich to give to the poor.  My delusions of becoming acting royalty resulted in...